Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
VGHCX vs PHSTX
Shared holdings
24
VGHCX covered by PHSTX
49.23%
PHSTX covered by VGHCX
49.23%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
VGHCX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 9.78% | |
| ASTRAZENECA PLC | 5.50% | |
| MERCK & CO | 5.09% | |
| UNITEDHEALTH GRP | 3.49% | |
| JOHNSON&JOHNSON | 3.11% | |
| EDWARDS LIFESCIENCES CORP | 3.11% | |
| GSK PLC | 2.99% | |
| DANAHER CORP | 2.70% | |
| ABBOTT LABS | 2.58% | |
| INTUITIVE SURGICAL INC | 2.50% | |
| ARGENX SE | 2.50% | |
| CENCORA INC | 2.41% | |
| UCB SA | 2.35% | |
| ABBVIE INC | 2.30% | |
| MEDTRONIC PLC | 2.25% | |
| VERTEX PHARMACEUTICALS INC | 1.91% | |
| CVS HEALTH CORP | 1.85% | |
| ELEVANCE HEALTH INC | 1.66% | |
| CARDINAL HEALTH INC | 1.56% | |
| NOVARTIS AG-REG | 1.44% | |
| ROCHE HLDG-GENUS | 1.40% | |
| BIOGEN INC | 1.34% | |
| GALDERMA GROUP A | 1.25% | |
| OTSUKA HOLDINGS | 1.21% | |
| AGILENT TECHNOLOGIES INC | 1.19% | |
| HCA HEALTHCARE INC | 1.16% | |
| CHUGAI PHARMA CO | 1.15% | |
| ALNYLAM PHARMACEUTICALS INC | 1.13% | |
| GENMAB AS | 1.12% | |
| UNITED THERAPEUTICS CORP DEL | 1.07% | |
| THERMO FISHER SCIENTIFIC INC | 1.04% | |
| BOSTON SCIENTIFIC CORP | 0.98% | |
| SHIONOGI & CO | 0.98% | |
| DEXCOM INC | 0.87% | |
| DAIICHI SANKYO | 0.86% | |
| IONIS PHARMACEUTICALS INC | 0.80% | |
| BRISTOL-MYERS SQUIBB CO | 0.75% | |
| STRYKER CORP | 0.71% | |
| QIAGEN NV | 0.70% | |
| STERIS PLC | 0.68% | |
| CYTOKINETICS INC | 0.65% | |
| ASCENDIS PHA-ADR | 0.64% | |
| STRUCTURE THERAPEUTICS INC DEPOSITARY RECEIPT | 0.63% | |
| BOA-MTG TRIPARTY REPO | 0.61% | |
| EISAI CO LTD | 0.61% | |
| REGENERON PHARMACEUTICALS INC | 0.60% | |
| REVOLUTION MEDICINES INC | 0.59% | |
| AVANTOR INC | 0.57% | |
| ICON PLC | 0.56% | |
| NOVO NORDISK-B | 0.53% |
PHSTX (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 11.32% | |
| JOHNSON&JOHNSON | 8.89% | |
| ABBVIE INC | 5.93% | |
| Novartis AG (Registered) | 5.52% | |
| MERCK & CO | 5.32% | |
| ASTRAZENECA PLC | 5.04% | |
| UNITEDHEALTH GRP | 4.92% | |
| INTUITIVE SURGICAL INC | 3.89% | |
| THERMO FISHER SCIENTIFIC INC | 3.70% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 2.90% | |
| BOSTON SCIENTIFIC CORP | 2.83% | |
| GILEAD SCIENCES INC | 2.68% | |
| MCKESSON CORP | 2.62% | |
| MEDTRONIC PLC | 2.47% | |
| Sanofi SA | 2.33% | |
| VERTEX PHARMACEUTICALS INC | 2.30% | |
| CARDINAL HEALTH INC | 2.27% | |
| BRISTOL-MYERS SQUIBB CO | 2.08% | |
| CVS HEALTH CORP | 1.84% | |
| Ascendis Pharma A/S | 1.67% | |
| EDWARDS LIFESCIENCES CORP | 1.62% | |
| HCA HEALTHCARE INC | 1.52% | |
| NOVO NORDISK-B | 1.45% | |
| Putnam Short Term Investment Fund, Class P | 1.32% | |
| ALNYLAM PHARMACEUTICALS INC | 1.31% | |
| CHUGAI PHARMA CO | 1.25% | |
| HOYA CORP | 1.24% | |
| REGENERON PHARMACEUTICALS INC | 1.23% | |
| UCB SA | 1.04% | |
| ARGENX SE | 1.01% | |
| ABBOTT LABS | 0.99% | |
| BECTON DICKINSON and CO | 0.98% | |
| GSK PLC | 0.95% | |
| VAXCYTE INC | 0.88% | |
| INSMED INC | 0.84% | |
| RHYTHM PHARMACEUTICALS INC | 0.63% | |
| US ULTRA BOND CBT Sep25 | 0.43% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.25% | |
| PRECIGEN INC | 0.22% | |
| Putnam Cash Collateral Pool LLC | 0.15% | |
| U.S. Treasury Bills | 0.12% | |
| U.S. Treasury Bills | 0.03% | |
| FX Spot Contract: EUR/USD SETTLE 2026-01-05 | 0.00% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.